AngioDynamics (NASDAQ: ANGO) revenue
AngioDynamics reported revenue of $320.2m for fiscal 2026, 9.5% more than in fiscal 2025 ($292.5m). Since fiscal 2017 its revenue has grown by 18.7%, an average growth of 1.9% a year.
AngioDynamics's best year of the last 10 was fiscal 2023. The biggest drop was in fiscal 2024, −10.3%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2026 | $320.2m | +9.5% | −$39.9m | −12.5% |
| 2025 | $292.5m | −3.8% | −$40.0m | −13.7% |
| 2024 | $303.9m | −10.3% | −$192.4m | −63.3% |
| 2023 | $338.8m | +7.1% | −$51.2m | −15.1% |
| 2022 | $316.2m | +8.7% | −$28.5m | −9.0% |
| 2021 | $291.0m | +10.2% | −$35.3m | −12.1% |
| 2020 | $264.2m | −2.4% | −$167.1m | −63.3% |
| 2019 | $270.6m | +3.4% | −$9.4m | −3.5% |
| 2018 | $261.7m | −3.0% | −$14.2m | −5.4% |
| 2017 | $269.8m | — | −$11.2m | −4.1% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
AngioDynamics revenue compared with its sector
By revenue for its latest fiscal year, AngioDynamics ranks 216th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; AngioDynamics, 9.5%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 214th | Tactile Systems Technology | $329.5m | 12.5% |
| 215th | Fulgent Genetics | $322.7m | 13.8% |
| 216th | AngioDynamics | $320.2m | 9.5% |
| 217th | Cormedix | $311.7m | 617.0% |
| 218th | PROCEPT BioRobotics | $308.1m | 37.2% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of AngioDynamics
- How much revenue did AngioDynamics make in fiscal 2026?
- AngioDynamics reported revenue of $320.2m for fiscal 2026, compared with $292.5m in fiscal 2025.
- How much has the revenue of AngioDynamics grown?
- Between fiscal 2017 and fiscal 2026 it went from $269.8m to $320.2m: 18.7% more, an average growth of 1.9% a year.
- What was the best year for revenue at AngioDynamics?
- Of its last 10 fiscal years, fiscal 2023, with $338.8m.
- Where does AngioDynamics rank in its sector by revenue?
- It ranks 216th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for AngioDynamics come from?
- From the annual report (Form 10-K) that AngioDynamics files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that AngioDynamics files with the SEC. The filing for each fiscal year: 2026 · 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017. More on AngioDynamics: the AngioDynamics page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.